Lv1
50 积分 2023-06-10 加入
Development and Validation of a Sensitive LC–MS/MS Method for Determination of Lenvatinib and Its Major Metabolites in Human Plasma and Its Application in Hepatocellular Carcinoma Patients
2个月前
已完结
Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer
3个月前
已完结
Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer
3个月前
已完结
Metabolism and pharmacokinetic study of deuterated osimertinib
3个月前
已完结
Simultaneous Determination of Icotinib, Osimertinib, Aumolertinib, and Anlotinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS
3个月前
已完结
Development and validation of an LC-MS/MS method for quantification of Osimertinib and its two metabolites AZ7550 and AZ5104 in human plasma including long-time storage
3个月前
已完结
Rate, Risk Factors, and Outcomes of Invasive Fungal Infections in Patients with Hematologic Malignancies
4个月前
已完结
A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction
4个月前
已完结
Population Pharmacokinetics of Isavuconazole in Hematologic Patients: Implications for Model-Informed Precision Dosing
4个月前
已完结
皖公网安备34019202002308
